Related Experiment Video
Updated: May 29, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
An Efficient and Explainable Ensemble-learning Framework for Early Lung Cancer Biomarkers Detection
Abstract:
This study proposes an Efficient and Explainable Ensemble-learning framework (EEE-framework) designed for early detection of non-small cell lung cancer (NSCLC) biomarkers using gene expression data, specifically addressing challenges of interpretability in detection outcomes. The EEE-framework comprises two core modules. The first module constructs an ensemble-learning model balancing detection accuracy and interpretability. Considering the typical trade-off between accuracy and interpretability, we explore various combinations of 10 individual learners, ultimately selecting five (Decision Tree, Random Forest, XGBoost, AdaBoost, and Gaussian Naive Bayes) with high interpretability as base learners. Subsequently, we classify NSCLC by integrating voting-ensemble with high interpretability. The second module develops a multi-perspective approach to identify important NSCLC biomarkers using six explainable artificial intelligence (XAI) methods, ranging from Local to Global Interpretability and from Intrinsic to Post-hoc Interpretability. The EEE-framework's generalization ability and interpretability are validated using the TCGA RNA_seq public dataset and a self-constructed methylation dataset. Validation results demonstrate the exceptional classification performance of the ensemble-learning model integrated in the framework, achieving F1 values of 0.9983(AUC:0.9993) and 0.8462(AUC:0.9249) on the two datasets, respectively. Global and Local Interpretable Visualization results significantly enhance the diagnosis and understanding of NSCLC biomarkers, providing insights to their importance rankings, interrelationships, and causality with predicted outcomes.
More Related Videos
Related Concept Videos
Statistical Methods for Analyzing Epidemiological Data
Comparing the Survival Analysis of Two or More Groups
Cancer Survival Analysis

